These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12013895)

  • 21. A cast-iron guarantee of ataxia and deafness.
    Shingde M; Ell J; Pamphlett R
    J Clin Neurosci; 2005 Sep; 12(7):807-8. PubMed ID: 16198920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ataxia-myoclonus-opsoclonus syndrome (author's transl)].
    Pinsard N; Pons-Cerdan C; Mancini J; Livet MO; Bernard R
    Ann Pediatr (Paris); 1980 May; 27(5):269-75. PubMed ID: 7235509
    [No Abstract]   [Full Text] [Related]  

  • 23. The movement disorder of adult opsoclonus.
    Caviness JN; Forsyth PA; Layton DD; McPhee TJ
    Mov Disord; 1995 Jan; 10(1):22-7. PubMed ID: 7885352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An autopsy case of generalized seizures, myoclonus, blindness and deafness].
    Kawasaki Y; Kodayashi K; Fukutani Y; Suzuki M; Nakamura I; Kurachi M; Nonomura A
    No To Shinkei; 1990 Jun; 42(6):533-8. PubMed ID: 2206639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome).
    Vaamonde J; Muruzabal J; Tuñón T; Perez N; Artieda J; Rodriguez M; Obeso JA
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):128-32. PubMed ID: 1538218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mitochondrial recessive ataxia syndrome (MIRAS) and valproate toxicity].
    Hakonen AH; Isohanni P; Rantamäki M; Kälviäinen R; Nordin A; Uusimaa J; Paetau A; Udd B; Pihko H; Wartiovaara A
    Duodecim; 2010; 126(13):1552-9. PubMed ID: 20695297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mitochondrial cardiomyopathy].
    Tanaka M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():306-11. PubMed ID: 12013873
    [No Abstract]   [Full Text] [Related]  

  • 28. Mitochondrial RNA processing and translation: link between mitochondrial mutations and hearing loss?
    Fischel-Ghodsian N
    Mol Genet Metab; 1998 Oct; 65(2):97-104. PubMed ID: 9787101
    [No Abstract]   [Full Text] [Related]  

  • 29. [NARP (neurogenic muscle weakness, ataxia and retinitis pigmentosa)].
    Goto Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):164-5. PubMed ID: 11596355
    [No Abstract]   [Full Text] [Related]  

  • 30. [Wobble modification defect suppresses translational activity of tRNAs with MERRF and MELAS mutations].
    Yasukawa T; Suzuki T; Watanabe K; Yasukawa T; Ohta S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():197-201. PubMed ID: 12013848
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reversible white matter lesions and antithyroid antibodies in the cerebrospinal fluid in Hashimoto's encephalopathy: a case report].
    Wakai M; Nishikage H; Goshima K
    Rinsho Shinkeigaku; 2004 Jul; 44(7):432-7. PubMed ID: 15384704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choreas, hereditary and other ataxias, tics, myoclonus, and other movement disorders.
    Tolosa E; Berciano J
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):358-68. PubMed ID: 8507906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and morphological abnormalities of mitochondria harbouring the tRNA(Leu)(UUR) mutation in mitochondrial DNA derived from patients with maternally inherited diabetes and deafness (MIDD) and progressive kidney disease.
    van den Ouweland JM; Maechler P; Wollheim CB; Attardi G; Maassen JA
    Diabetologia; 1999 Apr; 42(4):485-92. PubMed ID: 10230654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicine. Metabolic defects tied to mitochondrial gene.
    Marx J
    Science; 2004 Oct; 306(5696):592-3. PubMed ID: 15498983
    [No Abstract]   [Full Text] [Related]  

  • 35. [MELAS].
    Goto Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():287-91. PubMed ID: 12013867
    [No Abstract]   [Full Text] [Related]  

  • 36. Mitochondrial rRNA and tRNA and hearing function.
    Xing G; Chen Z; Cao X
    Cell Res; 2007 Mar; 17(3):227-39. PubMed ID: 17199108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SANDO].
    Inoue Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():363-6. PubMed ID: 12013887
    [No Abstract]   [Full Text] [Related]  

  • 38. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.
    Hess JF; Parisi MA; Bennett JL; Clayton DA
    Nature; 1991 May; 351(6323):236-9. PubMed ID: 1755869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evolution of metazoan mitochondrial genome].
    Ueshima R
    Tanpakushitsu Kakusan Koso; 2005 Nov; 50(14 Suppl):1813-4. PubMed ID: 16318324
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ataxia-opsoclonus-myoclonus syndrome].
    Pinsard N; Pons-Cerdan C; Mancini J; Livet MO; Bernard R
    Sem Hop; 1981 Mar 8-15; 57(9-10):488-94. PubMed ID: 6261394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.